Quadrant Capital Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-548
| Closed | -$148K | – | 1375 |
|
|
2025
Q1 | $148K | Buy |
548
+302
| +123% | +$81.5K | 0.01% | 1420 |
|
|
2024
Q4 | $57.9K | Sell |
246
-5
| -2% | -$1.18K | ﹤0.01% | 1339 |
|
|
2024
Q3 | $69K | Buy |
251
+21
| +9% | +$5.78K | ﹤0.01% | 1281 |
|
|
2024
Q2 | $55.9K | Sell |
230
-1
| -0.4% | -$243 | ﹤0.01% | 1349 |
|
|
2024
Q1 | $34.5K | Sell |
231
-75
| -25% | -$11.2K | ﹤0.01% | 1589 |
|
|
2023
Q4 | $58.6K | Buy |
306
+31
| +11% | +$5.93K | 0.01% | 1304 |
|
|
2023
Q3 | $48.7K | Buy |
275
+23
| +9% | +$4.07K | ﹤0.01% | 1283 |
|
|
2023
Q2 | $47.9K | Sell |
252
-73
| -22% | -$13.9K | ﹤0.01% | 1282 |
|
|
2023
Q1 | $65.1K | Buy |
325
+19
| +6% | +$3.81K | 0.01% | 1077 |
|
|
2022
Q4 | $72.7K | Sell |
306
-5
| -2% | -$1.19K | 0.01% | 949 |
|
|
2022
Q3 | $62K | Buy |
311
+11
| +4% | +$2.19K | 0.01% | 920 |
|
|
2022
Q2 | $44K | Buy |
300
+7
| +2% | +$1.03K | 0.01% | 923 |
|
|
2022
Q1 | $47K | Sell |
293
-59
| -17% | -$9.46K | 0.01% | 945 |
|
|
2021
Q4 | $60K | Sell |
352
-52
| -13% | -$8.86K | 0.01% | 850 |
|
|
2021
Q3 | $76K | Buy |
404
+39
| +11% | +$7.34K | 0.01% | 711 |
|
|
2021
Q2 | $62K | Buy |
365
+37
| +11% | +$6.29K | 0.01% | 761 |
|
|
2021
Q1 | $46K | Buy |
328
+72
| +28% | +$10.1K | 0.01% | 847 |
|
|
2020
Q4 | $33K | Sell |
256
-167
| -39% | -$21.5K | 0.01% | 888 |
|
|
2020
Q3 | $62K | Buy |
423
+237
| +127% | +$34.7K | 0.01% | 593 |
|
|
2020
Q2 | $28K | Sell |
186
-630
| -77% | -$94.8K | 0.01% | 924 |
|
|
2020
Q1 | $89K | Buy |
816
+15
| +2% | +$1.64K | 0.01% | 622 |
|
|
2019
Q4 | $90K | Buy |
801
+81
| +11% | +$9.1K | 0.01% | 1033 |
|
|
2019
Q3 | $56K | Buy |
720
+288
| +67% | +$22.4K | 0.01% | 1174 |
|
|
2019
Q2 | $30K | Sell |
432
-89
| -17% | -$6.18K | ﹤0.01% | 1444 |
|
|
2019
Q1 | $46K | Buy |
521
+440
| +543% | +$38.8K | 0.01% | 1266 |
|
|
2018
Q4 | $5K | Sell |
81
-12
| -13% | -$741 | ﹤0.01% | 1622 |
|
|
2018
Q3 | $8K | Buy |
93
+12
| +15% | +$1.03K | ﹤0.01% | 1370 |
|
|
2018
Q2 | $7K | Sell |
81
-45
| -36% | -$3.89K | ﹤0.01% | 1417 |
|
|
2018
Q1 | $14K | Buy |
126
+45
| +56% | +$5K | 0.01% | 1105 |
|
|
2017
Q4 | $10K | Hold |
81
| – | – | ﹤0.01% | 1169 |
|
|
2017
Q3 | $9K | Hold |
81
| – | – | ﹤0.01% | 1209 |
|
|
2017
Q2 | $6K | Buy |
+81
| New | +$6K | ﹤0.01% | 1261 |
|
|
2016
Q4 | – | Sell |
-123
| Closed | -$7K | – | 1986 |
|
|
2016
Q3 | $7K | Hold |
123
| – | – | ﹤0.01% | 1147 |
|
|
2016
Q2 | $6K | Buy |
123
+108
| +720% | +$5.27K | ﹤0.01% | 1153 |
|
|
2016
Q1 | $0 | Sell |
15
-54
| -78% | – | ﹤0.01% | 1797 |
|
|
2015
Q4 | $6K | Buy |
+69
| New | +$6K | ﹤0.01% | 961 |
|